Product Images Nabumetone

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Nabumetone NDC 69097-965 by Cipla Usa Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Structure - nabumetone 1

Structure - nabumetone 1

6MNA - nabumetone 2

6MNA - nabumetone 2

Figure - nabumetone 3

Figure - nabumetone 3

This is a graph showing the plasma concentrations of Nabumetone active metabolite at steady state following once-daily doses of either 1000 mg or 2000 mg. The x-axis shows time in hours, and the y-axis shows concentration in mg/mL. The graph shows that the concentration of Nabumetone active metabolite increases with the dose and peaks at around 7-8 hours after dosing. The standard deviations for the concentrations are also shown.*

This is a picture of the label Nabumetone tablets, USP, 750 mg, 100 count - nabumetone 500 mg Asc

This is a picture of the label Nabumetone tablets, USP, 750 mg, 100 count - nabumetone 500 mg Asc

Nabumetone Tablets are a prescription drug that comes in a pack of 100 tablets, with each tablet containing 500 mg of nabumetone USP. It is commonly used as a pain reliever and anti-inflammatory medication. Each patient is supposed to receive medication guidelines, as per the pharmacist's attention. It is manufactured by Ascent Pharmaceuticals, Inc. with the purpose of Cipla USA Inc. It is suggested to be stored in a light-resistant container within the USP-controlled room temperature range of 20-25 °C. The text also includes Pharmacy information for Dispensing the medication.*

This is a picture of the label Nabumetone tablets, USP, 500 mg, 100 count - nabumetone 500 mg Inv

This is a picture of the label Nabumetone tablets, USP, 500 mg, 100 count - nabumetone 500 mg Inv

This is a description of nabumetone tablets, a prescription medication by Cipla US. Each tablet contains 500 mg of nabumetone, and the usual dosage information is provided in the package insert. A medication guide is required for each patient. The tablets should be stored between 20-25°C and kept out of the reach of children in a tightly sealed and light-resistant container. The manufacturer is InvaGen Pharmaceuticals, Inc., a subsidiary of Cipla Lic. The tablets come in a bottle containing 100 units. The lot number is not discernible.*

This is a picture of the label Nabumetone tablets, USP, 500 mg, 100 count - nabumetone 750 mg Asc

This is a picture of the label Nabumetone tablets, USP, 500 mg, 100 count - nabumetone 750 mg Asc

This is a picture of the label Nabumetone tablets, USP, 500 mg, 100 count - nabumetone 750 mg Inv

This is a picture of the label Nabumetone tablets, USP, 500 mg, 100 count - nabumetone 750 mg Inv

Nabumetone is a prescription drug that comes in the form of tablets. Each tablet contains 750mg of nabumetone USP. Patients must receive a medication guide. The package insert should be seen for full prescribing information. The tablets must be stored at 20 to 25°C (68 to 77°F) and dispensed in a tightly closed, light-resistant container with a child-resistant closure. Nabumetone is manufactured by InvaGen Pharmaceuticals, Inc, a subsidiary of Cipla Limited, while Cipla USA, Inc distributes it in a 100 tablet bottle. Keep this and all medications out of the reach of children.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.